[go: up one dir, main page]

ZA200105429B - Remedial agent for erectile dysfunction. - Google Patents

Remedial agent for erectile dysfunction. Download PDF

Info

Publication number
ZA200105429B
ZA200105429B ZA200105429A ZA200105429A ZA200105429B ZA 200105429 B ZA200105429 B ZA 200105429B ZA 200105429 A ZA200105429 A ZA 200105429A ZA 200105429 A ZA200105429 A ZA 200105429A ZA 200105429 B ZA200105429 B ZA 200105429B
Authority
ZA
South Africa
Prior art keywords
group
alkyl group
hydrogen atom
atom
substituted
Prior art date
Application number
ZA200105429A
Other languages
English (en)
Inventor
Keizo Tanikawa
Nobutomo Tsuruzoe
Norimasa Shudo
Toru Yamashita
Norihisa Ishiwata
Hideaki Kido
Hajime Ebisu
Kazutaka Hayashi
Yoshiji Kubo
Norifumi Nakamura
Original Assignee
Nissan Chemical Ind Ltd
Weldfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd, Weldfide Corp filed Critical Nissan Chemical Ind Ltd
Publication of ZA200105429B publication Critical patent/ZA200105429B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200105429A 1998-12-07 2001-07-02 Remedial agent for erectile dysfunction. ZA200105429B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34679898 1998-12-07

Publications (1)

Publication Number Publication Date
ZA200105429B true ZA200105429B (en) 2002-07-02

Family

ID=18385894

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200105429A ZA200105429B (en) 1998-12-07 2001-07-02 Remedial agent for erectile dysfunction.

Country Status (15)

Country Link
EP (1) EP1157694A4 (no)
KR (1) KR100633869B1 (no)
CN (1) CN1163230C (no)
AU (1) AU768825B2 (no)
CA (1) CA2353956C (no)
CZ (1) CZ20012020A3 (no)
IL (2) IL143530A0 (no)
NO (1) NO321797B1 (no)
NZ (1) NZ512754A (no)
RU (1) RU2229885C2 (no)
SK (1) SK286984B6 (no)
TW (1) TW585767B (no)
UA (1) UA73104C2 (no)
WO (1) WO2000033845A1 (no)
ZA (1) ZA200105429B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063250A1 (ja) * 2003-12-26 2005-07-14 Nissan Chemical Industries, Ltd. 好中球増多抑制剤
KR20070029133A (ko) * 2004-02-09 2007-03-13 닛산 가가쿠 고교 가부시키 가이샤 혈관 내막 비후 억제약
RU2536425C2 (ru) * 2013-01-17 2014-12-20 Общество с ограниченной ответственностью "Фармамед" Фармацевтическая композиция, содержащая силденафил цитрат, и способ ее приготовления
JP6865933B2 (ja) 2018-02-23 2021-04-28 株式会社Ｍｅｉｓ Ｔｅｃｈｎｏｌｏｇｙ 勃起不全治療剤
CN113546049B (zh) * 2021-04-30 2023-03-17 贵州汉方药业有限公司 一种柔性丸剂药物黏合剂及使用该黏合剂制成的柔性丸剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW326041B (en) * 1993-12-16 1998-02-01 Nippon Nouyaku Kk Pyridazinone derivatives, their production process and their use for inhibition of platelet aggregation
PT742211E (pt) * 1994-01-25 2000-10-31 Nissan Chemical Ind Ltd Derivados de piridazinona
IL112695A (en) * 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives
EP0920868A4 (en) * 1996-08-20 2004-05-26 Eisai Co Ltd A CONDENSED PYRIDAZINE COMPOUND HEALING AGENT FOR ERECTIONAL DISEASES
TW482675B (en) * 1997-01-31 2002-04-11 Green Cross Corp Compositions for oral administration containing pyridazinone compounds technical field of the invention
AU8886298A (en) * 1997-08-28 1999-03-22 Nissan Chemical Industries Ltd. Neovascularization promoters and neovascularization potentiators
WO1999021558A2 (en) * 1997-10-28 1999-05-06 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction

Also Published As

Publication number Publication date
TW585767B (en) 2004-05-01
NZ512754A (en) 2002-10-25
EP1157694A1 (en) 2001-11-28
SK7062001A3 (en) 2001-11-06
CZ20012020A3 (cs) 2001-10-17
CN1329492A (zh) 2002-01-02
IL143530A0 (en) 2002-04-21
UA73104C2 (en) 2005-06-15
SK286984B6 (sk) 2009-08-06
CA2353956C (en) 2008-10-28
NO20012616L (no) 2001-08-07
IL143530A (en) 2006-12-31
KR20010081067A (ko) 2001-08-25
AU1413100A (en) 2000-06-26
NO20012616D0 (no) 2001-05-29
NO321797B1 (no) 2006-07-03
RU2229885C2 (ru) 2004-06-10
WO2000033845A1 (fr) 2000-06-15
EP1157694A4 (en) 2002-08-28
CN1163230C (zh) 2004-08-25
KR100633869B1 (ko) 2006-10-16
CA2353956A1 (en) 2000-06-15
AU768825B2 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
CN1742731B (zh) 治疗雌性性机能障碍的吡唑并嘧啶酮类
KR100559192B1 (ko) 혈관신생 촉진제 및 혈관신생 작용증강제
US5480888A (en) Inhibitor for restenosis after percutaneous coronary arterioplasty
DE69331546T2 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
ZA200105429B (en) Remedial agent for erectile dysfunction.
US6979687B1 (en) Theophylline-based soluble guanylyl cyclase activators KMUP-1 analogues enhanced cyclic GMP and K+ channel activities on rabbit corpus cavernosum smooth muscle and intercavernous pressure activities
US7754767B2 (en) Method for treatment of premature ejaculation in humans
JPH03215426A (ja) 血糖上昇抑制剤
EP0273375A2 (en) Propiophenone derivatives for treatment of pollakiuria (frequency urination)
US4871738A (en) Use of 2-pyrimidinyl-1-piperazine derivatives in the treatment of dependence on nicotine
EP0744950B1 (en) Agent for prophylaxis and treatment of thromboxane a2 mediated diseases
EP1064944A1 (en) Protein kinase N inhibitor comprising Fasudil
EP0664127B1 (en) Pharmaceutical compositions containing isoquinoline derivatives
US4424228A (en) Antihypertensive agent comprising a thiazolidine carboxylic acid and probenecid
ES2378374T3 (es) Inhibidores de la PDE 4 para el tratamiento de la cistitis intersticial
US4153700A (en) Treatment of the acute after-effects resulting from alcohol ingestion
EP1123704B1 (en) Remedies for spinal canal stenosis
MXPA01005701A (en) Remedial agent for erectile dysfunction
WO2002022127A1 (en) Use of phosphodiesterase inhibitors for the treatment of anorectal disorders
US3012938A (en) Inhibition of isoniazid acetylation
JP3388775B2 (ja) 脳障害改善剤
HU206612B (en) Process for producing antihypertenzive combinative composition
JPH07121864B2 (ja) 脳障害抑制作用を有する医薬組成物
CA2714160A1 (en) A method of administering a pde3 inhibitor via titration for the treatment of peripheral arterial disease